Bioabsorbable Stents Market by Biomaterial, Application, and End User - Global Industry Analysis and Forecast to 2027
Published On : May 2022 Pages : 105 Category: Medical Devices Report Code : HC0510
Industry Trend Analysis
Bioabsorbable stents market is expected to reach to $8 billion by 2027. This market growth is primarily attributed to the growing number of cardiovascular surgeries worldwide and offering more benefits when compared with other stents. Moreover, rapidly aging population which is more prone to strokes and needs a stent implant for treatment is set to further drive the market growth. While these stents are currently used in typical blockage cases, experts believe that market will disrupt once these stents are evolved to last longer and applied in more complicated procedures. The potential also lies in the peripheral artery problems where traditional stents have not shown promising results. Also, patients undergoing angioplasty have a high risk of restenosis where bioabsorbale stents prove to be helpful. Increase adoption rate of these devices will further drive this market. However, high complication risk and slow adoption for disease management can slow down the bioabsorbable stents market.
Product Outlook and Trend Analysis
Polymeric stents have wide applications in cardiovascular devices. Different types of polymers that are used in these stents are polyglycolic acid, polycaprolactone and poly-L-lactic acid. In metallic stents, magnesium bioabsorbable stents are the most commonly used stents in disease management. These have a considerably lower degradation time as compared to other types of metallic stents.
Application Outlook and Trend Analysis
Coronary artery disease market is expected to have the highest growth rate during the forecast period. These are used for treating coronary artery disease which could lead to a cardiac arrest. Peripheral artery diseases arise when arteries in the limbs are narrowed which reduces the flow of blood through the limbs leading to leg pain and skin ulcers. Diabetes is one of the prime causes for peripheral artery diseases.
Regional Outlook and Trend Analysis
North America dominates the global market for bioabsorbable stents due to the rising awareness about the benefits of using bioabsorbable stents for treating coronary ailments. Also, advanced technological innovations in these types of stents are also driving the market growth in this region. In Europe, Germany, Italy, France and UK hold the major share for bioabsorbable stents market.
Asia-Pacific market is expected to witness a high growth rate over the forecast period. Rising awareness about different coronary diseases and rapid adoption of bioabsorbable stents will drive this market growth substantially.
Competitive Analysis
The bioabsorbable stents market is dominated by a few large global players as it requires advanced infrastructure and heavy capital investments. Some of the key players in this market include, Abbott Laboratories Inc., Boston Scientific Corporation, Terumo Europe NV, Biotronik, Elixir Medical Corporation, Medtronic plc, Microport Scientific Corporation, Reva Medical, Inc, Arterial Remodeling Technologies, and Kyoto Medical Planning. Co. Ltd.
Market Opportunities
Increasing risk of cardiovascular diseases in obese people and increase in cardiovascular surgeries propose a huge scope for bioabsorbable stents market. These stents eliminate the need for dual anti-platelet therapies and increase the efficiency of treatment of coronary artery related disorders. Rising awareness in developing nations will also fuel the market growth over the forecast period. Technological advancements to increase the utility of these stents will improve the value proposition of bioabsorbable stents.
Bioabsorbable Stents Market Segmentation
By Biomaterial:
- Metallic Stents
- Polymeric Stents
By Application:
- Peripheral Artery Disease
- Coronary Artery Disease
By End User:
- Cardiac Centers
- Hospitals
By Region:
- North America
- U.S
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia Pacific
- Rest of the World
- Brazil
- South Africa
- Saudi Arabia
- United Arab Emirates
- Others
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2022 to 2027?
- What will be the industry market growth from 2022 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
- Bioabsorbable Stents Market By Biomaterial, Estimates and Forecast, 2017-2027 ($Million)
- Polymeric Stents
- Metallic Stents
- Bioabsorbable Stents Market By Application, Estimates and Forecast, 2017-2027 ($Million)
- Coronary Artery Diseases
- Peripheral Artery Diseases
- Bioabsorbable Stents Market By End User, Estimates and Forecast, 2017-2027 ($Million)
- Hospitals
- Cardiac Centers
- Bioabsorbable Stents Market By Region, Estimates and Forecast, 2017-2027 ($Million)
- North America
- North America Bioabsorbable Stents Market, By Country
- North America Bioabsorbable Stents Market, By Biomaterial
- North America Bioabsorbable Stents Market, By Application
- North America Bioabsorbable Stents Market, By End User
- U.S. Diabetes Devices Market, By Biomaterial
- U.S. Diabetes Devices Market, By Application
- U.S. Diabetes Devices Market, By End User
- Canada Diabetes Devices Market, By Biomaterial
- Canada Diabetes Devices Market, By Application
- Canada Diabetes Devices Market, By End User
- Mexico Diabetes Devices Market, By Biomaterial
- Mexico Diabetes Devices Market, By Application
- Mexico Diabetes Devices Market, By End User
-
- Europe
- Europe Bioabsorbable Stents Market, By Country
- Europe Bioabsorbable Stents Market, By Biomaterial
- Europe Bioabsorbable Stents Market, By Application
- Europe Bioabsorbable Stents Market, By End User
- Germany Diabetes Devices Market, By Biomaterial
- Germany Diabetes Devices Market, By Application
- Germany Diabetes Devices Market, By End User
- France Diabetes Devices Market, By Biomaterial
- France Diabetes Devices Market, By Application
- France Diabetes Devices Market, By End User
- UK Diabetes Devices Market, By Biomaterial
- UK Diabetes Devices Market, By Application
- UK Diabetes Devices Market, By End User
- Italy Diabetes Devices Market, By Biomaterial
- Italy Diabetes Devices Market, By Application
- Italy Diabetes Devices Market, By End User
- Spain Diabetes Devices Market, By Biomaterial
- Spain Diabetes Devices Market, By Application
- Spain Diabetes Devices Market, By End User
- Rest of Europe Diabetes Devices Market, By Biomaterial
- Rest of Europe Diabetes Devices Market, By Application
- Rest of Europe Diabetes Devices Market, By End User
-
- Asia-Pacific
- Asia-Pacific Diabetes Devices Market, By Country
- Asia-Pacific Diabetes Devices Market, By Biomaterial
- Asia-Pacific Diabetes Devices Market, By Application
- Asia-Pacific Diabetes Devices Market, By End User
- Japan Diabetes Devices Market, By Biomaterial
- Japan Diabetes Devices Market, By Application
- Japan Diabetes Devices Market, By End User
- China Diabetes Devices Market, By Biomaterial
- China Diabetes Devices Market, By Application
- China Diabetes Devices Market, By End User
- Australia Diabetes Devices Market, By Biomaterial
- Australia Diabetes Devices Market, By Application
- Australia Diabetes Devices Market, By End User
- India Diabetes Devices Market, By Biomaterial
- India Diabetes Devices Market, By Application
- India Diabetes Devices Market, By End User
- South Korea Diabetes Devices Market, By Biomaterial
- South Korea Diabetes Devices Market, By Application
- South Korea Diabetes Devices Market, By End User
- Rest of Asia-Pacific Diabetes Devices Market, By Biomaterial
- Rest of Asia-Pacific Diabetes Devices Market, By Application
- Rest of Asia-Pacific Diabetes Devices Market, By End User
- Asia-Pacific
-
- Rest of the World
- Rest of the World Diabetes Devices Market, By Country
- Rest of the World Diabetes Devices Market, By Biomaterial
- Rest of the World Diabetes Devices Market, By Application
- Rest of the World Diabetes Devices Market, By End User
- Brazil Diabetes Devices Market, By Biomaterial
- Brazil Diabetes Devices Market, By Application
- Brazil Diabetes Devices Market, By End User
- South Africa Diabetes Devices Market, By Biomaterial
- South Africa Diabetes Devices Market, By Application
- South Africa Diabetes Devices Market, By End User
- Saudi Arabia Diabetes Devices Market, By Biomaterial
- Saudi Arabia Diabetes Devices Market, By Application
- Saudi Arabia Diabetes Devices Market, By End User
- Turkey Diabetes Devices Market, By Biomaterial
- Turkey Diabetes Devices Market, By Application
- Turkey Diabetes Devices Market, By End User
- United Arab Emirates Diabetes Devices Market, By Biomaterial
- United Arab Emirates Diabetes Devices Market, By Application
- United Arab Emirates Diabetes Devices Market, By End User
- Others Diabetes Devices Market, By Biomaterial
- Others Diabetes Devices Market, By Application
- Others Diabetes Devices Market, By End User
- Rest of the World
Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Share Analysis
3.3. Market Dynamics
3.3.1. Drivers
3.3.1.1. Rising Number of Cardiovascular Surgeries Globally
3.3.1.2. Rise in Aging Population
3.3.2. Restraints
3.3.2.1. High Risk of Complication
3.3.2.2. Slow Adoption in Disease Management
3.3.3. Opportunities
3.3.3.1. Rising Awareness about Cardiovascular Diseases in Developing Nations
3.4. Industry Trends
4. Bioabsorbable Stents Market, By Biomaterial
4.1. Introduction
4.2. Bioabsorbable Stents Market Assessment and Forecast, By Biomaterial, 2017-2027
4.3. Polymer Based Stents
4.3.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.4. Metal Based Stents
4.4.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5. Bioabsorbable Stents Market, By Application
5.1. Introduction
5.2. Bioabsorbable Stents Market Assessment and Forecast, By Application, 2017-2027
5.3. Coronary artery Stents
5.3.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5.4. Peripheral artery Stents
5.4.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
6. Bioabsorbable Stents Market, By End User
6.1. Introduction
6.2. Bioabsorbable Stents Market Assessment and Forecast, By End User, 2017-2027
6.3. Hospitals
6.3.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
6.4. Cardiac Centers
6.4.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
7. Bioabsorbable Stents Market, By Region
7.1. Introduction
7.2. Bioabsorbable Stents Market Assessment and Forecast, By Region, 2017-2027 ($Million)
7.3. North America
7.3.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
7.3.2. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
7.3.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.3.4. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.3.4.1. U.S.
7.3.4.1.1. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
7.3.4.1.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.3.4.1.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.3.4.2. Canada
7.3.4.2.1. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
7.3.4.2.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.3.4.2.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.3.4.3. Mexico
7.3.4.3.1. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
7.3.4.3.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.3.4.3.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.4. Europe
7.4.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
7.4.2. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
7.4.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.4.4. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.4.4.1. Germany
7.4.4.1.1. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
7.4.4.1.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.4.4.1.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.4.4.2. France
7.4.4.2.1. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
7.4.4.2.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.4.4.2.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.4.4.3. UK
7.4.4.3.1. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
7.4.4.3.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.4.4.3.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.4.4.4. Italy
7.4.4.4.1. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
7.4.4.4.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.4.4.4.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.4.4.5. Spain
7.4.4.5.1. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
7.4.4.5.2. Assessment and Forecast, By Application, 2017-2027 ($Million)
7.4.4.5.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.4.4.6. Russia
7.4.4.6.1. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
7.4.4.6.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.4.4.6.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.4.4.7. Rest of Europe
7.4.4.7.1. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
7.4.4.7.2. Assessment and Forecast, By Application, 2017-2027 ($Million)
7.4.4.7.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.5. Asia-Pacific
7.5.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
7.5.2. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
7.5.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.5.4. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.5.4.1. Japan
7.5.4.1.1. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
7.5.4.1.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.5.4.1.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.5.4.2. China
7.5.4.2.1. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
7.5.4.2.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.5.4.2.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.5.4.3. Australia
7.5.4.3.1. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
7.5.4.3.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.5.4.3.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.5.4.4. India
7.5.4.4.1. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
7.5.4.4.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.5.4.4.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.5.4.5. South Korea
7.5.4.5.1. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
7.5.4.5.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.5.4.5.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.5.4.6. Taiwan
7.5.4.6.1. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
7.5.4.6.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.5.4.6.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.5.4.7. Rest of Asia-Pacific
7.5.4.7.1. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
7.5.4.7.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.5.4.7.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.6. Rest of the World
7.6.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
7.6.2. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
7.6.3. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.6.4. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.6.4.1. Brazil
7.6.4.1.1. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
7.6.4.1.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.6.4.1.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.6.4.2. Turkey
7.6.4.2.1. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
7.6.4.2.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.6.4.2.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.6.4.3. Saudi Arabia
7.6.4.3.1. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
7.6.4.3.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.6.4.3.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.6.4.4. South Africa
7.6.4.4.1. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
7.6.4.4.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.6.4.4.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.6.4.5. United Arab Emirates
7.6.4.5.1. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
7.6.4.5.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.6.4.5.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7.6.4.6. Others
7.6.4.6.1. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
7.6.4.6.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
7.6.4.6.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
8. Company Profiles
8.1. Abbott Laboratories, Inc.
8.1.1. Business Overview
8.1.2. Product Portfolio
8.1.3. Key Financials
8.1.4. Strategic Developments
8.2. Boston Scientific corporation
8.2.1. Business Overview
8.2.2. Product Portfolio
8.2.3. Key Financials
8.2.4. Strategic Developments
8.3. Terumo Europe NV
8.3.1. Business Overview
8.3.2. Product Portfolio
8.3.3. Key Financials
8.3.4. Strategic Developments
8.4. Biotronik
8.4.1. Business Overview
8.4.2. Product Portfolio
8.4.3. Key Financials
8.4.4. Strategic Developments
8.5. Elixir Medical Corporation
8.5.1. Business Overview
8.5.2. Product Portfolio
8.5.3. Strategic Developments
8.6. Medtronic, Inc.
8.6.1. Business Overview
8.6.2. Product Portfolio
8.6.3. Key Financials
8.6.4. Strategic Developments
8.7. Microport Scientific Corporation
8.7.1. Business Overview
8.7.2. Product Portfolio
8.7.3. Key Financials
8.7.4. Strategic Developments
8.8. Reva Medical, Inc.
8.8.1. Business Overview
8.8.2. Product Portfolio
8.8.3. Key Financials
8.8.4. Strategic Developments
8.9. Arterial Remodeling Technologies
8.9.1. Business Overview
8.9.2. Product Portfolio
8.9.3. Strategic Developments
8.10. Kyoto Medical Planning. Co. Ltd.
8.10.1. Business Overview
8.10.2. Product Portfolio
8.10.3. Strategic Developments
List of Tables
Table 1.Global Bioabsorbable Stents Market, By Biomaterial ($Million), 2017-2025
Table 2.PolymerBased Stents Market, By Region ($Million), 2017-2025
Table 3.Metal Based Stents Market, By Region ($Million), 2017-2025
Table 4.Global Bioabsorbable Stents Market, By Application ($Million), 2017-2025
Table 5.Coronary Artery StentsMarket, By Region ($Million), 2017-2025
Table 6.Peripheral Artery Stents Market, By Region ($Million), 2017-2025
Table 7.Global Bioabsorbable Stents Market, By End User ($Million), 2017-2025
Table 8.Hospitals Market, By Region ($Million), 2017-2025
Table 9.Cardiac Centers Market, By Region ($Million), 2017-2025
Table 10.Bioabsorbable Stents Market, By Region, 2017-2025 ($Million)
Table 11.North America Bioabsorbable Stents Market, By Country, 2017-2025 ($Million)
Table 12.North America Bioabsorbable Stents Market, By Biomaterial, 2017-2025 ($Million)
Table 13.North America Bioabsorbable Stents Market, By Application, 2017-2025 ($Million)
Table 14.North America Bioabsorbable Stents Market, By End User, 2017-2025 ($Million)
Table 15.U.S. Diabetes Devices Market, by Biomaterial, 2017-2025 ($Million)
Table 16.U.S. Diabetes Devices Market, by Application, 2017-2025 ($Million)
Table 17.U.S. Diabetes Devices Market, by End User, 2017-2025 ($Million)
Table 18.Canada Bioabsorbable Stents Market, By Biomaterial, 2017-2025 ($Million)
Table 19.Canada Bioabsorbable Stents Market, By Application, 2017-2025 ($Million)
Table 20.Canada Bioabsorbable Stents Market, By End User, 2017-2025 ($Million)
Table 21.Mexico Bioabsorbable Stents Market, By Biomaterial, 2017-2025 ($Million)
Table 22.Mexico Bioabsorbable Stents Market, By Application, 2017-2025 ($Million)
Table 23.Mexico Bioabsorbable Stents Market, By End User, 2017-2025 ($Million)
Table 24.Europe Bioabsorbable Stents Market, By Country, 2017-2025 ($Million)
Table 25.Europe Bioabsorbable Stents Market, By Biomaterial, 2017-2025 ($Million)
Table 26.Europe Bioabsorbable Stents Market, By Application, 2017-2025 ($Million)
Table 27.Europe Bioabsorbable Stents Market, By End User, 2017-2025 ($Million)
Table 28.Germany Bioabsorbable Stents Market, By Biomaterial, 2017-2025 ($Million)
Table 29.Germany Bioabsorbable Stents Market, By Application, 2017-2025 ($Million)
Table 30.Germany Bioabsorbable Stents Market, By End User, 2017-2025 ($Million)
Table 31.France Bioabsorbable Stents Market, By Biomaterial, 2017-2025 ($Million)
Table 32.France Bioabsorbable Stents Market, By Application, 2017-2025 ($Million)
Table 31.France Bioabsorbable Stents Market, By End User, 2017-2025 ($Million)
Table 32.UK Bioabsorbable Stents Market, By Biomaterial, 2017-2025 ($Million)
Table 33.UK Bioabsorbable Stents Market, By Application, 2017-2025 ($Million)
Table 34.UK Bioabsorbable Stents Market, By End User, 2017-2025 ($Million)
Table 35.Italy Bioabsorbable Stents Market, By Biomaterial, 2017-2025 ($Million)
Table 36.Italy Bioabsorbable Stents Market, By Application, 2017-2025 ($Million)
Table 37.Italy Bioabsorbable Stents Market, By End User, 2017-2025 ($Million)
Table 38.Spain Bioabsorbable Stents Market, By Biomaterial, 2017-2025 ($Million)
Table 39.Spain Bioabsorbable Stents Market, By Application, 2017-2025 ($Million)
Table 40.Spain Bioabsorbable Stents Market, By End User, 2017-2025 ($Million)
Table 41.Russia Bioabsorbable Stents Market, By Biomaterial, 2017-2025 ($Million)
Table 42.Russia Bioabsorbable Stents Market, By Application, 2017-2025 ($Million)
Table 43.Russia Bioabsorbable Stents Market, By End User, 2017-2025 ($Million)
Table 44.Rest of Europe Bioabsorbable Stents Market, By Biomaterial, 2017-2025 ($Million)
Table 45.Rest of Europe Bioabsorbable Stents Market, By Application, 2017-2025 ($Million)
Table 46.Rest of Europe Bioabsorbable Stents Market, By End User, 2017-2025 ($Million)
Table 47.Asia-Pacific Bioabsorbable Stents Market, By Country, 2017-2025 ($Million)
Table 48.Asia-Pacific Bioabsorbable Stents Market, By Biomaterial, 2017-2025 ($Million)
Table 49.Asia-Pacific Bioabsorbable Stents Market, By Application, 2017-2025 ($Million)
Table 50.Asia-Pacific Bioabsorbable Stents Market, By End User, 2017-2025 ($Million)
Table 51.Japan Bioabsorbable Stents Market, By Biomaterial, 2017-2025 ($Million)
Table 52.Japan Bioabsorbable Stents Market, By Application, 2017-2025 ($Million)
Table 53.Japan Bioabsorbable Stents Market, By End User, 2017-2025 ($Million)
Table 54.China Bioabsorbable Stents Market, By Biomaterial, 2017-2025 ($Million)
Table 55.China Bioabsorbable Stents Market, By Application, 2017-2025 ($Million)
Table 56.China Bioabsorbable Stents Market, By End User, 2017-2025 ($Million)
Table 57.Australia Bioabsorbable Stents Market, By Biomaterial, 2017-2025 ($Million)
Table 58.Australia Bioabsorbable Stents Market, By Application, 2017-2025 ($Million)
Table 59.Australia Bioabsorbable Stents Market, By End User, 2017-2025 ($Million)
Table 60.India Bioabsorbable Stents Market, By Biomaterial, 2017-2025 ($Million)
Table 61.India Bioabsorbable Stents Market, By Application, 2017-2025 ($Million)
Table 62.India Bioabsorbable Stents Market, By End User, 2017-2025 ($Million)
Table 63.South Korea Bioabsorbable Stents Market, By Biomaterial, 2017-2025 ($Million)
Table 64.South Korea Bioabsorbable Stents Market, By Application, 2017-2025 ($Million)
Table 65.South Korea Bioabsorbable Stents Market, By End User, 2017-2025 ($Million)
Table 66.Taiwan Bioabsorbable Stents Market, By Biomaterial, 2017-2025 ($Million)
Table 67.Taiwan Bioabsorbable Stents Market, By Application, 2017-2025 ($Million)
Table 68.Taiwan Bioabsorbable Stents Market, By End User, 2017-2025 ($Million)
Table 69.Rest of Asia-Pacific Bioabsorbable Stents Market, By Biomaterial, 2017-2025 ($Million)
Table 70.Rest of Asia-Pacific Bioabsorbable Stents Market, By Application, 2017-2025 ($Million)
Table 71.Rest of Asia-Pacific Bioabsorbable Stents Market, By End User, 2017-2025 ($Million)
Table 72.Rest of the World Bioabsorbable Stents Market, By Country, 2017-2025 ($Million)
Table 73.Rest of the World Bioabsorbable Stents Market, By Biomaterial, 2017-2025 ($Million)
Table 74.Rest of the World Bioabsorbable Stents Market, By Application, 2017-2025 ($Million)
Table 75.Rest of the World Bioabsorbable Stents Market, By End User, 2017-2025 ($Million)
Table 76.Brazil Bioabsorbable Stents Market, By Biomaterial, 2017-2025 ($Million)
Table 77.Brazil Bioabsorbable Stents Market, By Application, 2017-2025 ($Million)
Table 78.Brazil Bioabsorbable Stents Market, By End User, 2017-2025 ($Million)
Table 79.Turkey Bioabsorbable Stents Market, By Biomaterial, 2017-2025 ($Million)
Table 80.Turkey Bioabsorbable Stents Market, By Application, 2017-2025 ($Million)
Table 81.Turkey Bioabsorbable Stents Market, By End User, 2017-2025 ($Million)
Table 82.Saudi Arabia Bioabsorbable Stents Market, By Biomaterial, 2017-2025 ($Million)
Table 83.Saudi Arabia Bioabsorbable Stents Market, By Application, 2017-2025 ($Million)
Table 84.Saudi Arabia Bioabsorbable Stents Market, By End User, 2017-2025 ($Million)
Table 85.South Africa Bioabsorbable Stents Market, By Biomaterial, 2017-2025 ($Million)
Table 86.South Africa Bioabsorbable Stents Market, By Application, 2017-2025 ($Million)
Table 87.South Africa Bioabsorbable Stents Market, By End User, 2017-2025 ($Million)
Table 88.United Arab Emirates Bioabsorbable Stents Market, By Biomaterial, 2017-2025 ($Million)
Table 89.United Arab Emirates Bioabsorbable Stents Market, By Application, 2017-2025 ($Million)
Table 90.United Arab Emirates Bioabsorbable Stents Market, By End User, 2017-2025 ($Million)
Table 91.Others Bioabsorbable Stents Market, By Biomaterial, 2017-2025 ($Million)
Table 92.Others Bioabsorbable Stents Market, By Application, 2017-2025 ($Million)
Table 93.Others Bioabsorbable Stents Market, By End User, 2017-2025 ($Million)
Table 94.Abbott Laboratories: Key Strategic Developments, 2017-2017
Table 95.Boston Scientific Corporation: Key Strategic Developments, 2017-2017
Table 96.Terumo Europe NV: Key Strategic Developments, 2017-2017
Table 97.Biotronik: Key Strategic Developments, 2017-2017
Table 98.Elixir Medical Corporation: Key Strategic Developments, 2017-2017
Table 99.Medtronic: Key Strategic Developments, 2017-2017
Table 100.Microport Scientific Corporation: Key Strategic Developments, 2017-2017
Table 101.Reva Medical, Inc: Key Strategic Developments, 2017-2017
Table 102.Arterial Remodeling Technologies: Key Strategic Developments, 2017-2017
Table 103.Kyoto Medical Planning Co. Ltd: Key Strategic Developments, 2017-2017
List of Figures
Figure 1.Global Bioabsorbable Stents Market Share, By Biomaterial, 2017 & 2025
Figure 2.Bioabsorbable Stents Market, By Application, 2017 ($Million)
Figure 3.Bioabsorbable StentsMarket, By End User, 2017 ($Million)
Figure 4.Bioabsorbable StentsMarket, By Region, 2017 ($Million)
Figure 5.Abbott Laboratories: Net Revenues, 2017-2017 ($Million)
Figure 6.Abbott Laboratories: Net Revenue Share, By Segment, 2017
Figure 7.Abbott Laboratories: Net Revenue Share, By Geography, 2017
Figure 8.Boston Scientific Corporation: Net Revenues, 2017-2017 ($Million)
Figure 9.Boston Scientific Corporation: Net Revenue Share, By Segment, 2017
Figure 10.Boston Scientific Corporation: Net Revenue Share, By Geography, 2017
Figure 11.Terumo Europe NV: Net Revenues, 2017-2017 ($Million)
Figure 12.Terumo Europe NV: Net Revenue Share, By Segment, 2017
Figure13.Terumo Europe NV: Net Revenue Share, By Geography, 2017
Figure14.Biotronik: Net Revenues, 2017-2017 ($Million)
Figure15.Biotronik: Net Revenue Share, By Segment, 2017
Figure16.Biotronik: Net Revenue Share, By Geography, 2017
Figure 17.Medtronic: Net Revenues, 2017-2017 ($Million)
Figure18.Medtronic: Net Revenue Share, By Segment, 2017
Figure 19.Medtronic: Net Revenue Share, By Geography, 2017
Figure 20.Microport Scientific Corporation: Net Revenues, 2017-2017 ($Million)
Figure 21.Microport Scientific Corporation: Net Revenue Share, By Segment, 2017
Figure 22.Microport Scientific Corporation: Net Revenue Share, By Geography, 2017
Figure 23.Reva Medical, Inc: Net Revenues, 2017-2017 ($Million)
Figure 24.Reva Medical, Inc: Net Revenue Share, By Segment, 2017
Figure 25.Reva Medical, Inc: Net Revenue Share, By Geography, 2017
Figure 26.Arterial Remodeling Technologies, Inc: Net Revenues, 2017-2017 ($Million)
Figure 27.Arterial Remodeling Technologies, Inc: Net Revenue Share, By Segment, 2017
Figure 28.Arterial Remodeling Technologies, Inc: Net Revenue Share, By Geography, 2017
Figure 29.Kyoto Medical Planning. Co. Ltd.: Net Revenues, 2017-2017 ($Million)
Figure 30.Kyoto Medical Planning. Co. Ltd.: Net Revenue Share, By Segment, 2017
Figure 31.Kyoto Medical Planning. Co. Ltd.: Net Revenue Share, By Geography, 2017
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|